Why the study?
Readmissions within 1 year after PCI are common, but their long-term implications are not well characterised.
Does early or late unplanned readmission within 1 year post-PCI predict adverse long-term outcomes at 3 years?
Does early or late unplanned readmission within 1 year post-PCI predict adverse long-term outcomes at 3 years?
Unplanned readmissions in the first year following PCI, particularly those occurring more than 30 days after discharge, are associated with a significantly higher risk of MACE and death at 3 years.
Answers are grounded in this paper and cite their sources.
Late post-PCI readmission flags higher 3-year MACE and mortality risk; leaves open whether targeted interventions improve outcomes.
BACKGROUND: Readmissions within 1 year after percutaneous coronary intervention (PCI) are common (18.6-50.4% in international series) and a burden to patients and health services, however their long-term implications are not well characterised. We compared predictors of 30-day (early) and 31-day to 1-year (late) unplanned readmission and the impact of unplanned readmission on long-term clinical outcomes post-PCI. METHODS: Patients enrolled in the GenesisCare Cardiovascular Outcomes Registry (GCOR-PCI) from 2008 to 2020 were included in the study. Multivariate logistic regression analysis was performed to identify predictors of early and late unplanned readmission. A Cox proportion hazards regression model was used to explore the impact of any unplanned readmission during the first year post-PCI on the clinical outcomes at 3 years. Finally, patients with early and late unplanned readmission were compared to determine which group was at the highest risk of adverse long-term outcomes. Late compared with early unplanned readmission within the first year of PCI was more frequently associated with subsequent unplanned readmission, MACE and death between 1 and 3 years post-PCI. CONCLUSIONS: Unplanned readmissions in the first year following PCI, particularly those occurring more than 30 days after discharge, were associated with a significantly higher risk of adverse outcomes, such as MACE and death at 3 years. Strategies to identify patients at high risk of readmission and interventions to reduce their greater risk of adverse events should be implemented post-PCI.
No takes yet. Share an insight, caveat, or question.
Eccleston et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: